Data / Form D filings / Triton Therapeutics, Inc.
Triton Therapeutics, Inc.: Form D filing
Triton Therapeutics, Inc., a pharmaceuticals company in Stamford, CT, filed a Form D with the SEC in 2025. The latest, on October 23, 2025, reports $36.4 million sold of a $36.4 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 700 FAIRFIELD AVENUE, SUITE 1, Stamford, CT, 06902
- Phone
- (203) 482-3123
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2088152
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | New notice | $36,355,769 | $36,355,769 | 4 | Oct 17, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Annie Mitsak | Director | |
| Timothy Shannon | Director | |
| Elena Grigoryeva | Director | |
| Paul Fonteyne | Executive Officer, Director |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Oct 20, 2025 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Triton Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.